|
Originally published In Press as doi:10.1074/jbc.M303948200 on May 8, 2003
J. Biol. Chem., Vol. 278, Issue 28, 25879-25886, July 11, 2003
Activation of the ATR-mediated DNA Damage Response by the HIV-1 Viral Protein R*
Mikhail Roshal ,
Baek Kim ,
Yonghong Zhu ¶,
Paul Nghiem || and
Vicente Planelles ** 
From the
Department of Microbiology and
Immunology, University of Rochester Cancer Center, Rochester, New York 14642,
¶DNAX Research, Inc., Palo Alto, California
94304, ||Department of Chemistry and Chemical
Biology, Howard Hughes Medical Institute, Harvard University, Cambridge,
Massachusetts 02138, and **Division of Cellular
Biology and Immunology, Department of Pathology, University of Utah School of
Medicine, Salt Lake City, Utah 84132
DNA damage is a universal inducer of cell cycle arrest at the G2
phase. Infection by the human immunodeficiency virus type 1 (HIV-1) also
blocks cellular proliferation at the G2 phase. The HIV-1 accessory
gene vpr encodes a conserved 96-amino acid protein (Vpr) that is
necessary and sufficient for the HIV-1-induced block of cellular
proliferation. In the present study, we examined a recently identified DNA
damage-signaling protein, the ATM- and Rad3-related protein, ATR, for its
potential role in the induction of G2 arrest by Vpr. We show that
inhibition of ATR by pharmacological inhibitors, by expression of the
dominant-negative form of ATR, or by RNA interference inhibits Vpr-induced
cell cycle arrest. As with DNA damage, activation of ATR by Vpr results in
phosphorylation of Chk1. This study provides conclusive evidence of activation
of the ATR-initiated DNA damage-signaling pathway by a viral gene product.
These observations are important toward understanding how HIV infection
promotes cell cycle disruption, cell death, and ultimately, CD4+ lymphocyte
depletion.
Received for publication, April 15, 2003
, and in revised form, May 6, 2003.
* This work was supported in part by National Institutes of Health Research
Grants R01AI49057 and R21AI054188 (to V. P.) and NR01AI49781 (to B. K.). The
costs of publication of this article were defrayed in part by the payment of
page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Supported by National Institutes of Health Grant T32AI49815.

To whom correspondence should be addressed: Dept. of Pathology, University of
Utah School of Medicine, 30 N. 1900 East, SOM 5C210, Salt Lake City, UT 84132.
Tel.: 801-581-8655; E-mail:
vicente.planelles{at}path.utah.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. H. Olma, M. Roy, T. Le Bihan, I. Sumara, S. Maerki, B. Larsen, M. Quadroni, M. Peter, M. Tyers, and L. Pintard
An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases
J. Cell Sci.,
April 1, 2009;
122(7):
1035 - 1044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. DeHart, A. Bosque, R. S. Harris, and V. Planelles
Human Immunodeficiency Virus Type 1 Vif Induces Cell Cycle Delay via Recruitment of the Same E3 Ubiquitin Ligase Complex That Targets APOBEC3 Proteins for Degradation
J. Virol.,
September 15, 2008;
82(18):
9265 - 9272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. McCall, P. L. Miliani de Marval, P. D. Chastain II, S. C. Jackson, Y. J. He, Y. Kotake, J. G. Cook, and Y. Xiong
Human Immunodeficiency Virus Type 1 Vpr-Binding Protein VprBP, a WD40 Protein Associated with the DDB1-CUL4 E3 Ubiquitin Ligase, Is Essential for DNA Replication and Embryonic Development
Mol. Cell. Biol.,
September 15, 2008;
28(18):
5621 - 5633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Blackford, R. K. Bruton, O. Dirlik, G. S. Stewart, A. M. R. Taylor, T. Dobner, R. J. A. Grand, and A. S. Turnell
A Role for E1B-AP5 in ATR Signaling Pathways during Adenovirus Infection
J. Virol.,
August 1, 2008;
82(15):
7640 - 7652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Skasko and B. Kim
Compensatory Role of Human Immunodeficiency Virus Central Polypurine Tract Sequence in Kinetically Disrupted Reverse Transcription
J. Virol.,
August 1, 2008;
82(15):
7716 - 7720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Huard, R. T. Elder, D. Liang, G. Li, and R. Y. Zhao
Human Immunodeficiency Virus Type 1 Vpr Induces Cell Cycle G2 Arrest through Srk1/MK2-Mediated Phosphorylation of Cdc25
J. Virol.,
March 15, 2008;
82(6):
2904 - 2917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. DeHart and V. Planelles
Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation
J. Virol.,
February 1, 2008;
82(3):
1066 - 1072.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wen, K. M. Duus, T. D. Friedrich, and C. M. C. de Noronha
The HIV1 Protein Vpr Acts to Promote G2 Cell Cycle Arrest by Engaging a DDB1 and Cullin4A-containing Ubiquitin Ligase Complex Using VprBP/DCAF1 as an Adaptor
J. Biol. Chem.,
September 14, 2007;
282(37):
27046 - 27057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ward, M. Bonaparte, J. Sacks, J. Guterman, M. Fogli, D. Mavilio, and E. Barker
HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts
Blood,
August 15, 2007;
110(4):
1207 - 1214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hrecka, M. Gierszewska, S. Srivastava, L. Kozaczkiewicz, S. K. Swanson, L. Florens, M. P. Washburn, and J. Skowronski
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle
PNAS,
July 10, 2007;
104(28):
11778 - 11783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Maxwell and M. J. Curcio
Host Factors That Control Long Terminal Repeat Retrotransposons in Saccharomyces cerevisiae: Implications for Regulation of Mammalian Retroviruses
Eukaryot. Cell,
July 1, 2007;
6(7):
1069 - 1080.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Li, R. T. Elder, K. Qin, H. U. Park, D. Liang, and R. Y. Zhao
Phosphatase Type 2A-dependent and -independent Pathways for ATR Phosphorylation of Chk1
J. Biol. Chem.,
March 9, 2007;
282(10):
7287 - 7298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schrofelbauer, Y. Hakata, and N. R. Landau
HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1
PNAS,
March 6, 2007;
104(10):
4130 - 4135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mishra, J. P. Mishra, and A. Kumar
Activation of JNK-dependent Pathway Is Required for HIV Viral Protein R-induced Apoptosis in Human Monocytic Cells: INVOLVEMENT OF ANTIAPOPTOTIC BCL2 AND c-IAP1 GENES
J. Biol. Chem.,
February 16, 2007;
282(7):
4288 - 4300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Terada and Y. Yasuda
Human Immunodeficiency Virus Type 1 Vpr Induces G2 Checkpoint Activation by Interacting with the Splicing Factor SAP145
Mol. Cell. Biol.,
November 1, 2006;
26(21):
8149 - 8158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Zimmerman, M. P. Sherman, J. L. Blackett, J. A. Neidleman, C. Kreis, P. Mundt, S. A. Williams, M. Warmerdam, J. Kahn, F. M. Hecht, et al.
Human Immunodeficiency Virus Type 1 Vpr Induces DNA Replication Stress In Vitro and In Vivo
J. Virol.,
November 1, 2006;
80(21):
10407 - 10418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Jamburuthugoda, P. Chugh, and B. Kim
Modification of Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Target Cells with Elevated Cellular dNTP Concentrations
J. Biol. Chem.,
May 12, 2006;
281(19):
13388 - 13395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ardon, E. S. Zimmerman, J. L. Andersen, J. L. DeHart, J. Blackett, and V. Planelles
Induction of g2 arrest and binding to cyclophilin a are independent phenotypes of human immunodeficiency virus type 1 vpr.
J. Virol.,
April 1, 2006;
80(8):
3694 - 3700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lai, E. S. Zimmerman, V. Planelles, and J. Chen
Activation of the ATR Pathway by Human Immunodeficiency Virus Type 1 Vpr Involves Its Direct Binding to Chromatin In Vivo
J. Virol.,
December 15, 2005;
79(24):
15443 - 15451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dahl, J. You, and T. L. Benjamin
Induction and Utilization of an ATM Signaling Pathway by Polyomavirus
J. Virol.,
October 15, 2005;
79(20):
13007 - 13017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yoshizuka, Y. Yoshizuka-Chadani, V. Krishnan, and S. L. Zeichner
Human Immunodeficiency Virus Type 1 Vpr-Dependent Cell Cycle Arrest through a Mitogen-Activated Protein Kinase Signal Transduction Pathway
J. Virol.,
September 1, 2005;
79(17):
11366 - 11381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Daniel, E. Marusich, E. Argyris, R. Y. Zhao, A. M. Skalka, and R. J. Pomerantz
Caffeine Inhibits Human Immunodeficiency Virus Type 1 Transduction of Nondividing Cells
J. Virol.,
February 15, 2005;
79(4):
2058 - 2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. DeHart, J. L. Andersen, E. S. Zimmerman, O. Ardon, D. S. An, J. Blackett, B. Kim, and V. Planelles
The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration
J. Virol.,
February 1, 2005;
79(3):
1389 - 1396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jurvansuu, K. Raj, A. Stasiak, and P. Beard
Viral Transport of DNA Damage That Mimics a Stalled Replication Fork
J. Virol.,
January 1, 2005;
79(1):
569 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Zimmerman, J. Chen, J. L. Andersen, O. Ardon, J. L. DeHart, J. Blackett, S. K. Choudhary, D. Camerini, P. Nghiem, and V. Planelles
Human Immunodeficiency Virus Type 1 Vpr-Mediated G2 Arrest Requires Rad17 and Hus1 and Induces Nuclear BRCA1 and {gamma}-H2AX Focus Formation
Mol. Cell. Biol.,
November 1, 2004;
24(21):
9286 - 9294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Coberley, J. J. Kohler, J. N. Brown, J. T. Oshier, H. V. Baker, M. P. Popp, J. W. Sleasman, and M. M. Goodenow
Impact on Genetic Networks in Human Macrophages by a CCR5 Strain of Human Immunodeficiency Virus Type 1
J. Virol.,
November 1, 2004;
78(21):
11477 - 11486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Daniel, J. G. Greger, R. A. Katz, K. D. Taganov, X. Wu, J. C. Kappes, and A. M. Skalka
Evidence that Stable Retroviral Transduction and Cell Survival following DNA Integration Depend on Components of the Nonhomologous End Joining Repair Pathway
J. Virol.,
August 15, 2004;
78(16):
8573 - 8581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yuan, M. Kamata, Y.-M. Xie, and I. S. Y. Chen
Increased Levels of Wee-1 Kinase in G2 Are Necessary for Vpr- and Gamma Irradiation-Induced G2 Arrest
J. Virol.,
August 1, 2004;
78(15):
8183 - 8190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Li, P.-Z. Tao, Y.-Z. Liu, and J.-D. Jiang
Geldanamycin, a Ligand of Heat Shock Protein 90, Inhibits the Replication of Herpes Simplex Virus Type 1 In Vitro
Antimicrob. Agents Chemother.,
March 1, 2004;
48(3):
867 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yang, Y. Yu, H. E. Hamrick, and P. J. Duerksen-Hughes
ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses
Carcinogenesis,
October 1, 2003;
24(10):
1571 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|